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Abstract
A number of vegetables have a high nitrate content which after ingestion can be reduced to nitrite by oral bacteria, and further to vaso-
protective NO endogenously. In the present study, two separate randomly controlled, single-blind, cross-over, postprandial studies were
performed in normotensive volunteers. Ambulatory blood pressure (BP) was measured over a 24 h period following consumption of either
four doses of beetroot juice (BJ), 0, 100, 250 and 500 g (n 18), or three bread products, control bread (0 g beetroot), red beetroot- and white
beetroot-enriched breads (n 14). Total urinary nitrate/nitrite (NOx) was measured at baseline, and at 2, 4 and 24 h post-ingestion. BJ con-
sumption significantly, and in a near dose-dependent manner, lowered systolic BP (SBP, P,0·01) and diastolic BP (DBP, P,0·001) over a
period of 24 h, compared with water control. Furthermore, bread products enriched with 100 g red or white beetroot lowered SBP and DBP
over a period of 24 h (red beetroot-enriched bread, P , 0·05), with no statistical differences between the varieties. Total urinary NOx
significantly increased following the consumption of 100 g (P,0·01), 250 g (P , 0·001) and 500 g BJ (P , 0·001) and after red beetroot-
enriched bread ingestion (P , 0·05), but did not reach significance for white beetroot-enriched bread compared with the no-beetroot
condition. These studies demonstrated significant hypotensive effects of a low dose (100 g) of beetroot which was unaffected by processing
or the presence of betacyanins. These data strengthen the evidence for cardioprotective BP-lowering effects of dietary nitrate-rich vegetables.
Key words: Beetroot: Blood pressure: Nitrate: Nitrite: Nitric oxide
High blood pressure (BP) or hypertension (BP of .140/
90 mmHg) is a major public health burden. Worldwide, in
2001, 13·5 % of all premature deaths were attributed to high
BP(1). Moreover, hypertension is a major risk factor for the
progression of CVD(2–4), the leading cause of death in England.
Individuals with uncontrolled hypertension are at an almost
3-fold higher risk of developing CVD compared with normoten-
sive individuals(5). Evidence suggests that a reduction in
mean diastolic BP (DBP) by 5–6 mmHg over 5 years would
decrease the incidence of stroke and CHD(6). Recent reports
have suggested that the treatment of hypertension should
occur before the disease evolves, in patients with prehyperten-
sion or in normotensives(7). Therefore, novel cost-effective
strategies are needed for the treatment of this condition.
Increased fruit and vegetable consumption protects against
CVD and hypertension(8,9). These cardioprotective effects
have previously been attributed to several different nutrients
found in vegetables such as antioxidant vitamins and flavo-
noids. However, clinical trials fail to ascertain the beneficial
effects(10,11). Although the health benefits from a diet rich in
fruits and vegetables are likely to be multi-factorial, epidemio-
logical studies have shown specific food groups such as green
leafy vegetables to have the greatest protection against CHD
and ischaemic stroke risk(12,13). Along with beetroot (Beta
vulgaris), these are among the highest nitrate-accumulating
vegetables.
The continuous production of NO by the endothelium plays
an important role in the maintenance of vascular homeostasis.
Hypertension and other risk factors for CVD may be partly
associated with a diminished release of NO into the arterial
wall(14), due to inefficient synthesis or increased oxidative
destruction. Increasing evidence suggests that NO can be bio-
synthesised in vivo following ingestion of inorganic nitrate(15)
or dietary nitrate from beetroot juice (BJ)(16), by a process that
*Corresponding author: Professor J. A. Lovegrove, email j.a.lovegrove@reading.ac.uk
Abbreviations: ABP, ambulatory blood pressure; BJ, beetroot juice; BP, blood pressure; DBP, diastolic blood pressure; NOx, nitrate/nitrite; SBP, systolic
blood pressure.
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is independent of the conventional L-arginine NO synthase
pathway. The activity of ingested nitrate relies on its conver-
sion to nitrite by commensal Gram-negative bacteria residing
in the oral cavity and enters the circulation after absorption
in the stomach. In the blood vessel wall(17) and erythro-
cytes(18), the nitrite is reduced to NO and other nitrogen
oxides, ultimately leading to vasodilation, BP maintenance
and protection against ischaemia–reperfusion injury(19).
Ingestion of 500 ml BJ by normotensives has been shown to
reduce BP, inhibit platelet aggregation and prevent endothelial
dysfunction induced by an acute ischaemic insult to the
forearm(16).
In addition, beetroot is particularly rich in betalains, a group
of nitrogen-containing colour compounds that are not com-
monly represented among edible plants. Betalains can be
divided into two subclasses: the red/purple betacyanins
which are responsible for the colour of red beetroot or the
yellow/orange betaxanthins that contribute to the colour of
yellow beetroot. White beetroot is deficient in betacyanins,
but no other differences between beetroot varieties have
been reported in the literature. Betalains have been shown
to act as antioxidants, by the donation of electrons(21,22),
and inhibit lipid peroxidation and haem decomposition
in vitro (23), suggesting a role of these compounds in protec-
tion against certain oxidative stress-related diseases, such as
hypertension and CVD.
In the present study, two novel studies were performed.
The aim of study 1 was to determine the dose-dependent
effect of nitrate-rich BJ on 24 h ambulatory BP (ABP) to estab-
lish the lowest dose of nitrate contained within BJ to have a
functional effect on BP. Bread is a versatile and widely
consumed food and may be an effective vehicle to increase
vegetable consumption without significant dietary changes.
Study 2 was performed to determine whether beetroot-
enriched bread had similar beneficial effects on BP as BJ,
and as a secondary objective to assess the impact of betalains
on BP reduction.
Methods and procedure
Subjects
The study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures invol-
ving human subjects were approved by the University of
Reading Research Ethics Committee (approval no.: study 1,
09/25; study 2, 09/48). All subjects gave their written informed
consent. Separate recruitment was carried out for each of the
studies. The subjects were recruited from the University of
Reading and the surrounding Reading areas by email, posters
and Internet advertisements. Potential subjects attended a
screening visit following a 12 h fast. BP and anthropometric
measurements were taken followed by two blood samples,
one of which was sent to the local hospital (Royal Berkshire
Hospital) for full blood count analysis and the second for
in-house analysis of fasting blood lipids, glucose, liver and
kidney function using the ILAB 600 (Instrumentation Labora-
tories Limited). Subjects were selected if they met the study
criteria of the following: no known liver disease, diabetes
mellitus or a diagnosed mycocardial infarction; no gall bladder
problems or abnormalities of fat metabolism; no subjects on
weight-reducing diets or taking medication likely to affect
BP; no vigorous exercise (.3 times/week, ,20 min each
session) or excess consumption of alcohol (.150 ml/week);
BMI , 30 kg/m2; BP , 150/90 mmHg and Hb in the range
of 138–182 g/l. None of the subjects smoked or had a history
of recent serious acute or chronic illness.
Experimental design
Subjects were recruited to take part in two separate random-
ised, controlled, single-blind, cross-over, test meal studies con-
ducted at the Hugh Sinclair Unit of Human Nutrition at the
University of Reading, during two separate periods from
June to September 2008 and June to November 2009. There
were at least 7 d washout period between each study day.
All subjects were asked to refrain from consuming alcohol
and caffeine or undertake any strenuous physical activity for
24 h before each intervention day and were provided with a
standard evening meal supplied before each visit. On each
study day, subjects arrived at 08.00 hours at the Hugh Sinclair
Unit of Human Nutrition at the University of Reading after
a 12 h fast. After a baseline urine sample, subjects were
fitted with an ABP monitor and four baseline measurements
were taken.
Study 1. The first study investigated the dose-dependent
effects of BJ in eighteen healthy normotensive males. They
were randomised to receive one of four different intervention
drinks: 0 g BJ (500 g water) as a control; 100 g BJ with 400 g
water; 250 g BJ with 250 g water and 500 g BJ (100 %
BJ; James White Drinks Limited). The control drink and
BJ drinks were all diluted with low-nitrate mineral water
(The Buxton Mineral Water Company Limited).
Study 2. A further study was performed in fourteen
healthy males to investigate the effects of red or white beet-
root-enriched bread products on BP. Subjects were randomly
assigned to one of three different intervention bread products
(Eccentricities Limited): 200 g white bread (control, 0 g beet-
root enrichment), or 200 g bread enriched with either white
or red beetroot (comprising 50 % of the total weight of
dough before baking). In both studies, ABP was measured
automatically every 15 min from 08.00 hours until 13.00
hours, every 30 min from 13.00 hours until 22.00 hours, and
every 60 min from 22.00 hours until 08.00 hours. Additionally,
urine samples were collected at baseline, 2 and 4 h after inter-
vention food consumption, and as an overnight collection
(24 h), which was returned the following morning. The
sample volumes were recorded, the urine was divided into
aliquots and frozen at 2208C for later analysis. During the
study days, subjects remained in a semi-recumbent position.
Dietary protocol and intervention meals
In both studies, subjects consumed a low-nitrate and -nitrite
diet 1 d before each study day. All study subjects were
instructed not to take any vitamins or minerals, or other
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dietary supplements for 1 week before and during the
intervention period. Standard, low-nitrate meals were pro-
vided for the night before the study day, and lunch and
dinner on study days (Sainsbury’s ‘Be Good to Yourself’
range; Sainsbury’s Limited).
The intervention meals given in study 1 consisted of dose 1:
0 g BJ (500 g water) as a control; dose 2: 100 g BJ with 400 g
water; dose 3: 250 g BJ with 250 g water and dose 4: 500 g
BJ (100 % BJ; James White Drinks Limited), corresponding to
,0·05 mmol nitrate, 2·3 mmol nitrate, 5·7 mmol nitrate and
11·4 mmol nitrate for dose 1: 0 g BJ; dose 2: 100 g BJ; dose 3:
250 g BJ and dose 4: 500 g BJ, respectively. The control
drink and BJ drinks were all diluted with low-nitrate mineral
water (The Buxton Mineral Water Company Limited). On
each study day, subjects received a standardised breakfast
(50 g Nestle´ Shreddies and 125 ml semi-skimmed milk).
The intervention meals given in study 2 consisted of the
following: 200 g white bread (control, 0 g beetroot enrichment),
or 200 g bread enriched with either white or red beetroot
(comprising 50 % of the total weight of dough before baking).
The bread (200 g) was served as sandwiches with 25 g
Philadelphia cheese spread. The beetroot used in the bread
was grown on the same farm under identical conditions
and soil (Marsh Produce). In addition, the quantity of
beetroot in the bread products was equivalent to 100 g BJ,
administered as the lowest dose from study 1 to have a func-
tional effect in human subjects. The nitrate concentrations
of the beetroot-enriched breads (200 g) were as follows:
,0·05 mmol nitrate, 1·8 and 1·6 mmol nitrate for no-beetroot,
red beetroot-enriched bread and white beetroot-enriched
bread, respectively. The composition of the intervention
meals is shown in Table 1.
Low-nitrate water was provided, which subjects were asked
to consume for the same period as the low-nitrate diet
(The Buxton Mineral Water Company Limited) and to drink
throughout the study day. The intervention foods were
given immediately after four baseline BP readings and a base-
line urine sample, at approximately 09.00 hours on study days.
Participants were asked to finish their intervention foods
within 15 min. To ensure compliance to the low-nitrate diet,
subjects were asked to fill in a 24 h dietary recall for 1 d
before the study days and after each study day.
Ambulatory 24 h blood pressure measurements
BP was measured using a non-invasive ABP monitor
(ABPM TM-243; A&D Instruments Limited), which met the
British Hypertension Society standards for accuracy and per-
formance. ABP monitors were fitted by one researcher at the
start of each study day and subjects were asked to leave the
monitors on for a period of 24 h. Subjects rested for at least
15 min before the BP monitors were fitted. All readings were
performed on the left arm on each study day. The cuff was
programmed to inflate automatically for a total period of
24 h post-juice or bread consumption. Once the volunteers
left the Nutrition Unit, they were instructed to avoid any stren-
uous cardiovascular exercise, until the end of the 24 h period.
At each subsequent BP measurement, volunteers were asked T
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to hang their arm loosely down the side of their body, while
keeping still until the end of the measurement. If walking,
the volunteers were instructed to stop and remain standing
while the measurement was being recorded. Volunteers
were provided with a 24 h BP diary card, which they were
required to fill in with information on their daily activities
throughout the 24 h period.
Total urinary nitrate/nitrite measurements
Nitrate/nitrite (NOx) measurements were carried out on urine
samples using a NO quantification kit (Active Motif). Creati-
nine was determined for all urine samples, using the ILAB
600 (Instrumentation Laboratories Limited). Total urinary
NOx determination was used as a surrogate marker of systemic
NO production. It should be noted that this measurement is
not a reliable index of NO bioactivity in vivo, but may be
used as an indicator of NO production.
Statistical analysis
All subjects who completed the study were included in
the data analysis. Data were analysed using Excel (Microsoft
Office; Microsoft Limited) and SPSS 18 for Microsoft Windows
(SPSS, Inc.). All data are expressed as means with their
standard errors of the mean and checked for normality using
the Shapiro–Wilk test, as the number of subjects was less
than fifty. Unpaired t tests were used to compare the two
study groups at baseline. The AUC was calculated as a
summation measure for BP. The period between 0 and 4 h
represents the time the participants spent in the Nutrition
Unit under standard resting conditions, 0 and 13 h represents
the total awake period, and 0 and 24 h includes the total
24 h period after intervention food ingestion. One-way
ANOVA was used for AUC comparisons, and subsequently
Bonferroni multiple pairwise comparison post hoc tests to
identify the differences between the control (no beetroot)
and 100, 250 and 500 g BJ and beetroot-enriched bread,
200 g white beetroot (100 g)-enriched bread and 200 g
red beetroot (100 g)-enriched bread. Urine sample data were
compared using repeated-measures ANOVA. In all cases,
P#0·05 was considered as statistically significant unless
otherwise stated.
Results
Subject characteristics
A total of eighteen men completed study 1 and fourteen men
completed study 2. There were no adverse events reported in
response to intervention products, apart from beeturia (red
urine), which is a common side effect of beetroot consump-
tion. Table 2 shows the mean and range of baseline character-
istics of the subjects. There were no significant differences in
the general characteristics of the individuals recruited for the
two separate studies.
24 h ambulatory blood pressure
There were no significant differences in systolic BP (SBP) and
DBP between the two groups during the hour before con-
sumption of BJ, beetroot-enriched bread or controls (Table 2).
Study 1 (beetroot juice dose–response study). Post-
prandial SBP and DBP after the ingestion of 0 g BJ (control),
100, 250 and 500 g BJ are shown in Fig. 1. SBP and DBP
began to decrease 90 min after the ingestion of all BJ interven-
tion drinks (100, 250 and 500 g BJ), in accordance with the
increasing dose of BJ. The peak reduction in SBP and DBP
occurred at 2–3 h in the order of 13·1, 20·5 and 22·2 mmHg
and 16·6, 14·6 and 18·3 for 100, 250 and 500 g BJ, respectively,
compared with the water control (0 g BJ). There was a signifi-
cant effect of treatment on the AUC for both SBP from 0 to 4 h
(Fig. 1(a), P¼0·008), 0 to 13 h (Fig. 1(c), P¼0·001) and 0 to
24 h (Fig. 1(e), P¼0·006) and DBP from 0 to 4 h (Fig. 1(b),
P¼0·001), 0 to 13 h (Fig. 1(d), P¼0·001) and 0 to 24 h
(Fig. 1(f), P¼0·001) after the consumption of 100, 250 and
500 g BJ, respectively. The Bonferroni post hoc test revealed
that after ingestion of 100, 250, 500 g BJ, SBP was significantly
lower from 0 to 4 h (Fig. 1(a), 250 g BJ, P¼0·04; 500 g BJ,
P¼0·008), 0 to 13 h (Fig. 1(c), 250 g BJ, P¼0·02; 500 g BJ,
P¼0·001) and for the remaining 24 h period (Fig. 1(e), 500 g
BJ, P¼0·004) compared with the control drink (water). DBP
was significantly lower from 0 to 4 h after ingestion of 100 g
BJ (Fig. 1(b), P¼0·002) and 500 g BJ (Fig. 1(b), P¼0·001), 0
to 13 h (Fig. 1(d), 100 g BJ, P¼0·003; 250 g BJ, P¼0·03; 500 g
BJ, P¼0·001) and for the remaining 24 h period (Fig. 1(f),
100 g BJ, P¼0·001; 250 g BJ, P¼0·02; 500 g BJ, P¼0·001) com-
pared with the control drink (water). In addition, mean heart
rate did not change significantly over the 24 h period post-
ingestion of water control, 100, 250 or 500 g BJ (69·9
(SEM 1·2), 69·2 (SEM 1·2), 70·9 (SEM 1·8) and 71·3 (SEM 1·3),
respectively). There appeared to be a near dose-dependent
effect from 0 to 24 h, as shown by the pattern of decreasing
AUC for increasing BJ dose (Fig. 1(e) and (f)).
Study 2 (beetroot-enriched bread study). Postprandial
SBP and DBP after the consumption of three different inter-
vention breads enriched with no beetroot (control), 100 g
white beetroot or 100 g red beetroot are shown in Fig. 2. BP
started decreasing approximately 60 min after the ingestion
Table 2. Baseline characteristics of the subjects before ingestion of
intervention juice (study 1) or bread products (study 2)
(Mean values with their standard errors, n 18 (study 1), n 14 (study 2))
Subjects
Study 1* Study 2*
Characteristics Mean SEM Mean SEM
Age (years) 31·4 3·0 25·1 0·8
BMI (kg/m2) 24·4 0·9 23·5 0·7
SBP (mmHg) 130·6 3·2 131·2 5·2
DBP (mmHg) 82·1 5·6 78·2 4·0
SBP, systolic blood pressure; DBP, diastolic blood pressure.
* There were no significant differences in baseline characteristics between the
participants in study 1 and study 2 (unpaired t test): P¼0·05.
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of beetroot-enriched breads compared with the bread control
(no beetroot). Peak differences in SBP and DBP occurred
between 2 and 3 h in the order of 19·3 and 23·6 mmHg and
16·5 and 23·2 mmHg for white and red beetroot-enriched
breads, respectively, compared with the control bread
(0 g beetroot). The AUC for SBP from 0 to 4 h following
beetroot-enriched bread consumption was lower for both
beetroot-enriched breads compared with the control bread
(Fig. 2(a)), which continued from 0 to 13 h (Fig. 2(c))
and for the remaining 24 h period (Fig. 2(e)), but did not
reach significance. However, there was a significant effect
of treatment on the AUC for DBP from 0 to 4 h (Fig. 2(b),
P¼0·03), 0 to 13 h (Fig. 2(d), P¼0·04) and from 0 to 24 h
(Fig. 2(f), P¼0·03). Following ingestion of bread enriched
with 100 g red beetroot, DBP was significantly lower from 0
to 4 h (P¼0·05), 0 to 13 h (P¼0·04) and 0 to 24 h (P¼0·03),
compared with the control bread (no beetroot). Following
ingestion of 200 g bread enriched with 100 g white beetroot,
DBP was lower compared with the control (0 g beetroot)
but did not reach significance. SBP was lower for both beet-
root-enriched bread interventions at all time points compared
with the control bread (0 g beetroot), but failed to reach
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Fig. 1. Study 1: mean change in area under the postprandial systolic blood pressure (SBP) curve from (a) 0 to 4 h, (c) 0 to 13 h and (e) 0 to 24 h and diastolic
blood pressure (DBP) from (b) 0 to 4 h, (d) 0 to 13 h and (f) 0 to 24 h following consumption of dose 1 (control, water, 0 g beetroot juice (BJ)), dose 2 (100 g BJ
with 400 g water), dose 3 (250 g BJ with 250 g water) and dose 4 (500 g BJ). All intervention drinks were made up to 500 g with low-nitrate water (The Buxton
Mineral Water Company Limited). Values are means, with standard errors of the mean represented by vertical bars. Mean values were significantly different from
the control drink (water): *P,0·05, **P,0·01, ***P,0·001; Bonferroni post hoc test.
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statistical significance. There were no statistical differences
between the red and white beetroot-enriched breads for
both DBP and SBP over the 24 h period after ingestion of
the intervention breads. In addition, mean heart rate did
not change significantly over the 24 h period after consump-
tion of the control bread (0 g beetroot), red or white beet-
root-enriched breads (73·6 (SEM 1·2), 74·9 (SEM 1·2) and 74·2
(SEM 1·1)).
Total urinary nitrate/nitrite
Study 1 (beetroot juice dose–response study). Total urinary
NOx were significantly higher for the 100 and 250 g BJ doses
from 0 to 4 h post-consumption compared with the 0 g BJ con-
trol (100 g BJ, P,0·01; 250 g BJ, P,0·001; Fig. 3(a)). Total
urinary NOx increased significantly from 0 to 4 h post-con-
sumption of 500 g BJ and remained significantly higher at
24 h compared with the 0 g BJ control (P,0·001; Fig. 3(a)).
Study 2 (beetroot-enriched bread study). Following con-
sumption of the beetroot-enriched breads, total urinary NOx
increased from 0 to 4 h, but only reached significance for
the red beetroot-enriched bread (P,0·05; Fig. 3(b)).
Discussion
One of the largest public health schemes in the Western world
in the past decade has been to increase fruit and vegetable
consumption. However, despite this, recent data from the
National Diet and Nutrition Survey highlight that the average
British adult consumes less than four portions of fruit and
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Fig. 2. Study 2: mean change in area under the postprandial systolic blood pressure (SBP) curve from (a) 0 to 4 h, (c) 0 to 13 h and (e) 0 to 24 h and diastolic
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vegetables a day. Interestingly, 64 g of white bread are con-
sumed by almost 80 % of British adults daily(24). Taken
together, these data suggest that enriching bread with fruit
or vegetables may be a novel and useful strategy to increase
the consumption of fruit and vegetables.
The protective effects of diets rich in fruit and vegetables
have previously been attributed to several antioxidant
vitamins. However, large-scale trials have failed to ascertain
these beneficial effects. Recently, it has been postulated that
the cardioprotective effects seen from consumption of green
leafy vegetables and beetroot may be due to their high dietary
nitrate content(16,25). Dietary nitrate generates NO indepen-
dently of the conventional endogenous NO synthase pathway,
by reduction to nitrite and subsequently to NO in vivo (25).
Since hypertension is associated with a diminished endogen-
ous NO production, the development of novel cost-effective
strategies to incorporate dietary nitrate and therefore
additional NO into the diet is of considerable interest.
Herein, we demonstrated that consumption of 100, 250 and
500 g BJ reduced SBP and DBP over a period of 24 h when
compared with the control drink (0 g beetroot). There was a
clear trend for BP reduction with increasing BJ dose, with a
dose as low as 100 g resulting in a significant BP-lowering
effect. A novel finding from these studies was that both SBP
and DBP were substantially lower following consumption of
bread enriched with either 100 g white or red beetroot, com-
pared with the control bread (0 g beetroot). Although this
only reached significance for red beetroot-enriched bread, it
suggests that processing had minimal impact on the physio-
logical effects of beetroot on BP. Therefore, enriching bread
with fruit and vegetables may prove to be a good vehicle
for increasing the intake of fruit and vegetables with minimal
impact on habitual diet. Previous studies have found a peak
decrease in SBP of 5·4 (SEM 1·5) and 10·4 (SEM 3·0) mmHg 2
to 3 h following consumption of 250 ml (5·5 mmol nitrate)(20)
and 500 ml (22·5 mmol nitrate)(16) BJ. In the present studies,
the peak SBP reductions were of greater magnitude. This
may be due to differences in baseline BP of the subjects in
the studies. Kapil et al.(20) found that the magnitude of BP
response was directly related to baseline BP. Thus, a higher
baseline BP would result in a greater magnitude of BP
reduction.
Total urinary NOx concentrations were measured as an
indicator of systemic NO production and increased in
accordance with reductions in BP after consumption of BJ
and beetroot-enriched breads. These results are in accordance
with previous findings which suggest that urinary nitrate
reaches peak concentrations 4–6 h and returns to baseline
24 h after supplementation with nitrate(26,27) and dietary
nitrate(28). The metabolic fate of NO includes oxidation to
nitrate by oxyhaemoglobin in erythrocytes and autoxidation
to nitrite. Nitrate and nitrite circulate in the blood and are
ultimately excreted in the urine. Total urinary NOx determi-
nation may be used as an index of systemic NO production,
but is not necessarily an indicator of endothelial NO synthase
activity in vivo.
Interestingly, white beetroot, a betacyanin-deficient variety,
lowered BP to a similar extent as red beetroot, a betalain-
abundant variety, compared with the control (0 g beetroot).
This observation suggests that components other than betalain
compounds are likely to be responsible for the BP-lowering
effects observed. Although beetroot contains other potentially
bioactive compounds such as vitamin C, folate, K, dietary fibre
and polyphenols, we suggest that it is the dietary nitrate that is
partly responsible for the beneficial effects observed from
beetroot consumption by bioconversion to nitrite and then
to NO in vivo. In humans, 20–25 % of ingested nitrate is
secreted in saliva and approximately 20 % of this is converted
to nitrite by commensal Gram-negative bacteria on the dorsal
surface of the tongue, resulting in nitrite-rich saliva(29). The
salivary nitrite is absorbed in the stomach and enters the circu-
lation where NO synthesis occurs by the reduction of nitrite
within the blood vessel wall(17) and erythrocytes(18). It is poss-
ible that the nitrite derived from ingested nitrate, in the present
studies, provided an intravascular source of NO that resulted
in vasodilation within the microcirculation to produce a
decrease in peripheral resistance and therefore a reduction
in BP.
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Fig. 3. Mean total urinary nitrate/nitrite (NOx) concentrations for (a) dose 1
(control, water, 0 g beetroot juice (BJ; )), dose 2 (100 g BJ with 400 g
water; ), dose 3 (250 g BJ with 250 g water; ) and dose 4 (500 g
BJ; ) and (b) 200 g control bread (0 g beetroot; ), 200 g bread
enriched with either 100 g white beetroot ( ) or 100 g red beetroot
( ) at baseline (0 h) and 2, 4 and 24 h consumption of intervention juices
or breads. Values are means, with standard errors of the mean represented
by vertical bars. Mean values were significantly different between the
groups, i.e. control juice (water), bread with BJ or beetroot-enriched bread:
*P,0·05, **P,0·01, ***P,0·001 (Bonferroni post hoc test); †P,0·05,
†††P,0·001(repeated-measures ANOVA).
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The hypothesis that it was the dietary nitrate present in the
BJ and beetroot-enriched breads that caused the beneficial
effects on BP was supported by a study showing that sup-
plementation of healthy volunteers with sodium nitrate
(0·1 mmol/kg per d) over 3 d reduced DBP by 3·7 mmHg,
compared with NaCl control(15). Moreover, the magnitude of
BP reduction and plasma nitrite concentration was diminished
when the enterosalivary circulation was interrupted by spitting
out all saliva following consumption of 500 ml BJ(16).
In the present studies, subjects were in a controlled environ-
ment, sitting or in a semi-recumbent position, for the first 4 h
after intervention drink and bread consumption. However, the
AUC for SBP remained lower following consumption of both
beetroot-enriched breads for up to 13 h post-consumption,
compared with the no-beetroot condition. This is noteworthy,
as it indicates that the BP-lowering effect was sustained
throughout the afternoon period, although understandably
less marked than the initial effect due to the confounding
effect of daily activities. This prolonged effect is suggestive
of the impact of colonic metabolic products causing further
release of NO into the circulation. It has been previously
reported that anaerobic gut flora can reduce nitrate to
nitrite(30). It is therefore possible that nitrite is further con-
verted to bioactive NO in the colon, which after absorption
exerts vasodilatory effects, therefore prolonging the effects
of BJ and bread on BP.
A limitation of these pilot studies is the lack of postprandial
blood samples. As a result, it is currently unknown how the
plasma nitrate and nitrite are affected by BJ or beetroot-
enriched bread ingestion and whether they occur in associ-
ation with changes in BP. Although determination of urinary
NOx concentrations is suggestive of an association between
BP-lowering effects of BJ and breads and nitrate consumption.
Another possible limitation is the relatively small number of
subjects who took part in these studies. However, even with
the limited number of participants, both studies were suitably
powered to detect significant BP changes. A larger postpran-
dial test meal study is being performed to verify these findings
and to investigate other parameters of vascular function such
as micro-vessel endothelial function.
In conclusion, results from these studies are the first to
demonstrate that acute ingestion of BJ lowered BP in a near
dose-dependent manner in healthy normotensive individuals.
In addition, novel bread enriched with either white or red
beetroot, equivalent to 100 g BJ, resulted in similar BP
reductions. This may suggest that nitrate in the beetroot is a
major contributor to the BP reduction observed, whereas beta-
lains had minimal impact, and that processing beetroot during
bread production did not have a significant impact on the
BP-lowering effects. Therefore, enriching bread with beetroot
may provide a useful vehicle for the delivery of dietary nitrate
and increasing vegetable consumption, with minimal impact
on dietary habits.
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